{
    "clinical_study": {
        "@rank": "1350", 
        "arm_group": [
            {
                "arm_group_label": "Morphology", 
                "arm_group_type": "Active Comparator", 
                "description": "Embryos selected for transfer will be based on morphology alone."
            }, 
            {
                "arm_group_label": "GemART assay", 
                "arm_group_type": "Experimental", 
                "description": "Embryos selected for transfer will be based upon morphology and GemART assay."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the performance of a genetic assay, GemART, in\n      cumulus cells predictive of embryo viability, and pregnancy success in women undergoing in\n      vitro fertilization (IVF).  Performance is defined as success rate per embryo transferred,\n      as measured by the implantation rate of embryos transferred."
        }, 
        "brief_title": "Gene Expression in Cumulus Cells to Predict Pregnancy", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged 21-39 years\n\n          -  IVF cycle 1 or 2\n\n          -  BMI <35\n\n          -  Fertilization method: ICSI and/or IVF\n\n          -  Day 3 or day 5 embryo transfer\n\n          -  Treatment cycle intended for single or double embryo transfer\n\n          -  Use own oocytes, not oocyte donor\n\n          -  \u2265 3 embryos at final assessment\n\n          -  Donor sperm acceptable\n\n          -  Willing to comply with protocol and study procedures\n\n        Exclusion Criteria:\n\n          -  Polycystic Ovarian Syndrome\n\n          -  Presence of fibroid(s): >4 cm intramural or submucosal fibroids\n\n          -  History of chemotherapy or radiation to the abdomen or pelvis\n\n          -  Use of donor oocytes\n\n          -  Use of reinseminated oocytes\n\n          -  Preimplantation genetic diagnosis or preimplantation genetic screening during current\n             IVF cycle\n\n          -  Concurrent participation in another clinical study\n\n          -  (Male): Surgically removed sperm\n\n          -  (Male): <5 million sperm count"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "39 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01732900", 
            "org_study_id": "GEMA-201201"
        }, 
        "intervention": [
            {
                "arm_group_label": "Morphology", 
                "description": "Embryos selected for transfer will be based upon morphology alone.", 
                "intervention_name": "Morphology", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "GemART assay", 
                "description": "Embryos selected for transfer will be based upon morphology and GemART assay.", 
                "intervention_name": "GemART assay", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "In vitro fertilization", 
            "Assisted reproduction", 
            "pregnancy outcome", 
            "cumulus cells"
        ], 
        "lastchanged_date": "February 25, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Oak Brook", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60523"
                    }, 
                    "name": "Reproductive Medicine Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46280"
                    }, 
                    "name": "IVF Indiana"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iowa City", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "52242"
                    }, 
                    "name": "University of Iowa"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Troy", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48084"
                    }, 
                    "name": "Reproductive Medicine Associates of Michigan"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Predictive Value of a Gene Expression Signature in Cumulus Cells Indicative of Embryo Implantation.", 
        "overall_official": {
            "affiliation": "IVF Indiana", 
            "last_name": "John Jarrett, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Clinical pregnancy, recorded as either positive or negative, will be determined using vaginal ultrasound during post-transfer week 4-9. Clinical Pregnancy rate for embryos selected using the GemART assay in conjunction with morphology will be compared with clinical pregnancy rate for embryos selected using morphology alone.", 
            "measure": "Clinical pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "Recorded at post-transfer week 4-9"
        }, 
        "reference": {
            "PMID": "23200692", 
            "citation": "Iager AE, Kocabas AM, Otu HH, Ruppel P, Langerveld A, Schnarr P, Suarez M, Jarrett JC, Conaghan J, Rosa GJ, Fern\u00e1ndez E, Rawlins RG, Cibelli JB, Crosby JA. Identification of a novel gene set in human cumulus cells predictive of an oocyte's pregnancy potential. Fertil Steril. 2012 Nov 29. doi:pii: S0015-0282(12)02385-0. 10.1016/j.fertnstert.2012.10.041. [Epub ahead of print]"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01732900"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Gema Diagnostics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gema Diagnostics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}